# OnCo record remix-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/remix-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "remix-therapeutics" ;
  schema:name "Remix Therapeutics"@en ;
  schema:alternateName "Remix Therapeutics, Inc."@en ;
  schema:description "Remix Therapeutics is a Massachusetts biotech that makes small molecules to change how RNA is processed; REM-422 destroys the messenger RNA for the transcription factor MYB, a driver of adenoid cystic carcinoma and acute myeloid leukaemia."@en ;
  schema:url <https://onco.cc/companies/remix-therapeutics/>, <https://www.remixtx.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.remixtx.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "US" ;
  onco:drugs <https://onco.cc/drugs/rem-422/> .